GraceGShumakerMD

Oncology • Jackson, MS

Physician

Join to view full profile

Are you Dr. Shumaker?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 92 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1227 N State St
Ste 101
Jackson, MS 39202
Phone+1 601-355-2485

Fax+1 601-353-1463

Summary

Dr. Grace Shumaker, MD is an oncologist in Jackson, Mississippi. She is currently licensed to practice medicine in Mississippi. She is affiliated with Mississippi Baptist Medical Center, University of Mississippi Medical Center, and St. Dominic-Jackson Memorial Hospital.

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1991 - 1993
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
University of Mississippi Medical CenterResidency, Internal Medicine, 1986 - 1990
University of Mississippi School of MedicineClass of 1986

Certifications & Licensure

MS State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014

Clinical Trials

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02
Terminated
Phase 3
A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
Completed
Phase 2
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Sep 16
Active, not recruiting
Phase 3
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Completed
Phase 3
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Completed
Phase 3
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Start of enrollment: 2017 Jun 07
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer
Helen K. Chew, Lee S. Schwartzberg, Suprith Badarinath, Peter Rubin, Grace Shumaker
Springerplus. 2014-02-22

Professional Memberships

American College of Physicians - ACP
Member